Agape ATP Corporation (NASDAQ:ATPC) Sees Large Growth in Short Interest

Agape ATP Corporation (NASDAQ:ATPC) was the recipient of a large increase in short interest in July. As of July 31st, there was short interest totaling 29,079 shares, an increase of 88.6% from the July 15th total of 15,420 shares. Currently, 3.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,579,723 shares, the days-to-cover ratio is currently 0.0 days.

Agape ATP Stock Performance

ATPC traded down $0.01 during midday trading on Friday, hitting $2.49. The stock had a trading volume of 19,484 shares, compared to its average volume of 454,781. The company has a market cap of $2.49 million, a P/E ratio of -1.87 and a beta of 0.38. The business has a fifty day moving average of $2.82 and a 200 day moving average of $2.81. Agape ATP has a 1 year low of $1.72 and a 1 year high of $73.50.

Agape ATP (NASDAQ:ATPC) last released its earnings results on Friday, August 14th. The company reported $0.15 EPS for the quarter. Agape ATP had a negative net margin of 125.89% and a negative return on equity of 8.43%. The company had revenue of $0.01 million for the quarter.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on ATPC. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Agape ATP in a report on Friday, May 22nd. Wall Street Zen upgraded Agape ATP from a “sell” rating to a “hold” rating in a research report on Monday, June 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Agape ATP currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Agape ATP

An institutional investor recently raised its position in Agape ATP stock. Citadel Advisors LLC lifted its position in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 65,130 shares of the company’s stock after purchasing an additional 31,849 shares during the period. Citadel Advisors LLC owned about 0.13% of Agape ATP worth $82,000 as of its most recent SEC filing. 0.01% of the stock is currently owned by institutional investors.

About Agape ATP

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.